Pipedream? I don't get what your talking about, when ace would hit the pipe he didn't sleep for days, hed just get busier than a mosquito in a nudist colony and start typing up the spam, but no dreamen. Ace says there be plenty of time for sleep when he's dead, he just loves that movie Roadhouse.
ACT has a number or irons in the fire --- AMD, SMD, blood program, patents, technologies. There are also additional things going on (Dr. Lanza is supporting on MS research). Each initiative that ACT is pursuing has the potential for blockbuster success. Doubling, tripling etc the fruition of successes could push the PPS over $1.
Probably the best scenario would be 3-4 sequential successes...AMD-- SMD-- licensing-- blood-- Roslin-- etc.
I am assuming based on recent events this year that RS may actually happen before Oct. Which would suggest the peer review article would need to come out before then for this stock to have what would be a snowballs chance in h___ of reaching a dollar. People who keep dreaming that the pps will go above a billion market cap or roughly .25 are in fact counting on unexplainable exuberance which of course fits into the category of anything is possible just not likely. Do you believe it's possible to win the lottery? Good luck.
No one is dreaming it-Maxim published that number (.45)-maybe they're expecting "exuberance", maybe the value of a cure exceeds $1B-this is a research co-the market cap is not a true value with these cos. as opposed to HSY-(let's say) a dependable market cap.
Tim, it can easily hit $1 per share pre-RS, if great news comes out, or if there's a merger with a big pharma firm.
The big thing would be getting the AMD & SMD cures to market, because those are huge markets worldwide, $50B+ at minimum. I think we can expect the EMA(European Medicines Agency) to approve these cures before the FDA does. And having a Englishman leading ACT is going to help a lot with the EMA approval.
Merger first before it is played out. The big pharma makes all the money. They are going to pay a
50% premium you will get a some shares in exchange. The new shares will be burdened with
the mass of the big pharma and move slowly over the years. Been there, done that.
English/African/Chinese heritage would help more! Only in Keep Land, products get to market (profitable market, not compassionate use) before P3 approval. $.45 by people that really analyze numbers-$1- the mice would to have x-ray vision